Increased circulating follicular helper T cells with decreased programmed death-1 in chronic renal allograft rejection
Open Access
- 3 November 2015
- journal article
- research article
- Published by Springer Nature in BMC Nephrology
- Vol. 16 (1) , 1-6
Abstract
Chronic antibody-mediated rejection is a major issue that affects long-term renal allograft survival. Since follicular helper T (Tfh) cells promote the development of antigen-specific B cells in alloimmune responses, we investigated the potential roles of Tfh cells, B cells and their alloimmune-regulating molecules in the pathogenesis of chronic renal allograft rejection in this study. The frequency of Tfh, B cells and the levels of their alloimmune-regulating molecules including chemokine receptor type 5 (CXCR5), inducible T cell co-stimulator (ICOS), programmed death-1 (PD-1), ICOSL, PDL-1 and interleukin-21 (IL-21), of peripheral blood were comparatively measured in 42 primary renal allograft recipients within 1–3 years after transplantation. Among them, 24 patients had definite chronic rejection, while other 18 patients had normal renal function. Tfh-cell ratio was significantly increased with PD-1 down-regulation in the patients with chronic renal allograft rejection, while B cells and the alloimmune-regulating molecules studied did not show any appreciable change in parallel. The patients with chronic renal allograft rejection have a characteristic increase in circulating Tfh cells with a decrease in PD-1 expression. These pathological changes may be a therapeutic target for the treatment of chronic renal allograft rejection and can be useful as a clinical index for monitoring conditions of renal transplant.Keywords
This publication has 36 references indexed in Scilit:
- Follicular T helper cells and humoral reactivity in kidney transplant patientsClinical and Experimental Immunology, 2015
- The good, the bad and the ugly — TFH cells in human health and diseaseNature Reviews Immunology, 2013
- CXCR5+ T helper cells mediate protective immunity against tuberculosisJournal of Clinical Investigation, 2013
- Effectiveness of Rituximab and Intravenous Immunoglobulin Therapy in Renal Transplant Recipients with Chronic Active Antibody-Mediated RejectionTransplantation Proceedings, 2012
- Blockade of B7-H1 (Programmed Death Ligand 1) Enhances Humoral Immunity by Positively Regulating the Generation of T Follicular Helper CellsThe Journal of Immunology, 2011
- Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinaseProceedings of the National Academy of Sciences, 2009
- Generation of T Follicular Helper Cells Is Mediated by Interleukin-21 but Independent of T Helper 1, 2, or 17 Cell LineagesImmunity, 2008
- T Follicular Helper (TFH) Cells in Normal and Dysregulated Immune ResponsesAnnual Review of Immunology, 2008
- Call for Revolution: A New Approach to Describing Allograft DeteriorationAmerican Journal of Transplantation, 2002
- In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. III. The kinetics of V region mutation and selection in germinal center B cells.Journal of Experimental Medicine, 1993